NLS Pharmaceutics Warrant
NLSPW
NLSPW was delisted on the 30th of October, 2025.
3 hedge funds and large institutions have $1.77K invested in NLS Pharmaceutics Warrant in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
3% more capital invested
Capital invested by funds: $1.71K → $1.77K (+$53)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
2.74% less ownership
Funds ownership: 2.74% → 0% (-2.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$469 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$250 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $1.03K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $731 | +$469 | +29,497 | +181% |
|
|
3
UBS Group
Zurich,
Switzerland
| $8 | +$7 | +424 | New |
|
|
AC
4
Armistice Capital
New York
| – | -$250 | -12,500 | Closed |
|
NLSPW Hedge Fund Activity: Q3 2025 in Review
3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in NLS Pharmaceutics Warrant (NLSPW) for Q3 2025, worth a combined $1.77K — up 3.1% from $1.71K a quarter earlier.
Fund positioning in NLSPW was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $469. The largest seller was Armistice Capital, exiting entirely with an estimated $250 sold.
- 3 institutional investors held NLS Pharmaceutics Warrant (NLSPW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $1.77K of NLS Pharmaceutics Warrant stock for Q3 2025, up 3.1% quarter-over-quarter.
- 1 fund opened new NLS Pharmaceutics Warrant positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest NLS Pharmaceutics Warrant buyer in Q3 2025 was Susquehanna International Group, an estimated $469 added.
- The largest NLS Pharmaceutics Warrant seller in Q3 2025 was Armistice Capital, an estimated $250 sold.
Based on aggregated 13F filings for Q3 2025.